HERANTIS PHARMA OYJ
502098-0412ActiveDeveloping disease-modifying therapies for Parkinson's disease progression.
Overview
- 0
- Employees
- Unknown
- Revenue
- 2025
- Founded
Key Decision Makers
Tone Kvåle
Chief Financial Officer
Henri Huttunen
Chief Scientific Officer
Timo Veromaa
Chairman of the Board
Hilde Furberg
Board Member
+4 more contacts in Funnelfeedr
Description
Herantis Pharma Plc is a clinical-stage biotechnology company dedicated to addressing the unmet medical need in neurodegenerative diseases. Their primary focus is developing disease-modifying therapies aimed at stopping or reversing disease progression, specifically targeting Parkinson's disease. Th...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Utländsk juridisk person
- VAT Number
- SE502098041201
Decision Makers
8 contacts in FunnelfeedrTone Kvåle
Chief Financial Officer
Henri Huttunen
Chief Scientific Officer
Timo Veromaa
Chairman of the Board
Hilde Furberg
Board Member
Antti Vuolanto
Chief Executive Officer
Aki Prihti
Board Member
Frans Wuite
Board Member
Mats Thorén
Board member
Similar Companies
20 similar companies in FunnelfeedrHMNC HOLDING GMBH
1–4 employeesPioneering precision psychiatry treatments using AI for mental health.
Grespo AB
0 employeesYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Polku Therapeutics Oy
Developing novel therapies for debilitating neurodegenerative diseases.
ScandiBio Therapeutics AB
0 employeesAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Egetis Therapeutics AB (publ)
20–49 employeesInnovative pharmaceutical company developing late-stage orphan drug treatments.
Browse More
HERANTIS PHARMA OYJ Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo